Health
Persistent antimicrobial resistance in the food chain underlines need for a ‘One Health’ approach
A joint assessment by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) warns that resistance in pathogens such as Salmonella and Campylobacter “continues to be a public health concern across Europe”.
At issue is the persistence, and in some cases rise, of resistance to ciprofloxacin, a frontline treatment for severe human infections. A “high proportion” of Salmonella and Campylobacter sampled from humans and food-producing animals show resistance to the drug. In Campylobacter, resistance has become so widespread that ciprofloxacin is “no longer recommended” for treating human infections. Restrictions on its veterinary use are intended to preserve what remains of its clinical utility.
More broadly, resistance to commonly used antimicrobials including ampicillin, tetracyclines and sulfonamides, remains elevated. Particularly troubling is the growing detection...

Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
Health5 days agoCounterfeit cigarettes drive illicit tobacco trade to highest level in a decade, new study claims
-
Libya5 days agoLibya’s fuel crisis offers lessons for energy security on both sides of the Mediterranean
-
Law4 days agoEU Cybersecurity Act could expose member states to costly investment treaty claims, legal opinion warns
-
Space5 days agoIn space, we can’t defend what we can’t see
